Johnson & Johnson’s Procept Biorobotics PRCT Stock Holding History

Johnson & Johnson’s Portfolio PRCT Stock Details PRCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.08M	Hold	357,939	–	–	1.01%	11
2026 Q1	$8.95M	Hold	357,939	–	–	1.37%	9
2025 Q4	$11.3M	Hold	357,939	–	–	2.03%	9
2025 Q3	$12.8M	Hold	357,939	–	–	2.54%	8
2025 Q2	$20.4M	Hold	357,939	–	–	6.1%	7
2025 Q1	$20.9M	Hold	357,939	–	–	6.1%	6
2024 Q4	$28.8M	Hold	357,939	–	–	7.46%	6
2024 Q3	$28.7M	Hold	357,939	–	–	6.71%	7
2024 Q2	$21.9M	Hold	357,939	–	–	5.46%	8
2024 Q1	$17.7M	Hold	357,939	–	–	0.4%	11
2023 Q4	$15M	Hold	357,939	–	–	0.34%	11
2023 Q3	$11.7M	Hold	357,939	–	–	4.33%	7
2023 Q2	$12.7M	Hold	357,939	–	–	3.93%	8
2023 Q1	$10.2M	Hold	357,939	–	–	3.31%	8
2022 Q4	$14.9M	Sell	357,939 -505,969	-59%	-$21.7M	4.33%	7
2022 Q3	$35.8M	Sell	863,908 -154,570	-15%	-$6.17M	10.54%	3
2022 Q2	$33.3M	Hold	1,018,478	–	–	8.51%	4
2022 Q1	$35.6M	Hold	1,018,478	–	–	6.74%	7
2021 Q4	$25.5M	Hold	1,018,478	–	–	2.9%	9
2021 Q3	$38.9M	Buy	+1,018,478	New	+$39.1M	3.41%	8

Other funds holding PRCT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Johnson & Johnson's PRCT Position: Q2 2026 in Review

Johnson & Johnson held its Procept Biorobotics (PRCT) position steady in Q2 2026 at 357,939 shares worth $8.08M. The position accounts for 1.01% of the portfolio, ranked #11.

Johnson & Johnson first reported a position in PRCT in Q3 2021 and has held it in 20 quarters since. The position peaked at $38.9M in Q3 2021. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

Johnson & Johnson held 357,939 shares of Procept Biorobotics worth $8.08M as of Q2 2026.
Johnson & Johnson left its Procept Biorobotics share count unchanged in Q2 2026.
Procept Biorobotics made up 1.01% of Johnson & Johnson's portfolio in Q2 2026, its #11 holding.
Johnson & Johnson first reported a position in Procept Biorobotics in Q3 2021 and has held it in 20 quarters since.
Johnson & Johnson's Procept Biorobotics position peaked at $38.9M in Q3 2021.
254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Johnson & Johnson's 13F filing for Q2 2026, filed 6 Aug 2026.